Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Su

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Pediatric Dermatology|October 17, 2017
Screening for Sturge-Weber syndrome: A state-of-the-art reviewMichaela Zallmann, Richard J Leventer, Mark T Mackay, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 8, 2018
The skin as a target for prevention of the atopic marchAdrian J Lowe, Donald Y M Leung, Mimi L K Tang, et al.
Acta Dermato-Venereologica|June 1, 2017
A Review of 52 Pedigrees with Epidermolysis Bullosa Simplex Identifying Ten Novel Mutations in KRT5 and KRT14 in AustraliaEmma N Kim, Adam G Harris, Linda J Bingham, et al.
American Journal of Clinical Dermatology|July 7, 2019
Artificial Intelligence in Dermatology-Where We Are and the Way to the Future: A ReviewDaniel T Hogarty, John C Su, Kevin Phan, et al.
The British Journal of Dermatology|July 13, 2022
The association between domestic hard water and eczema in adults from the UK Biobank cohort studyDiego J Lopez, Ankur Singh, Nilakshi T Waidyatillake, et al.
JAAD International|August 19, 2021
Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional studyJohn C Su, Nikolay Murashkin, Andreas Wollenberg, et al.
Acta Dermato-Venereologica|March 29, 2017
Debunking the Myth of Wool Allergy: Reviewing the Evidence for Immune and Non-immune Cutaneous ReactionsMichaela Zallmann, Pete K Smith, Mimi L K Tang, et al.
American Journal of Clinical Dermatology|May 15, 2023
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical StudyLawrence F Eichenfield, Richard G Gower, JinHua Xu, et al.
American Journal of Clinical Dermatology|March 27, 2020
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)Joel Schlessinger, Julie S Shepard, Richard Gower, et al.
Journal of the American Academy of Dermatology|December 21, 2013
Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)Clement C H Loh, Jaehwan Kim, John C Su, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Pediatric Dermatology|October 17, 2017
Screening for Sturge-Weber syndrome: A state-of-the-art reviewMichaela Zallmann, Richard J Leventer, Mark T Mackay, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 8, 2018
The skin as a target for prevention of the atopic marchAdrian J Lowe, Donald Y M Leung, Mimi L K Tang, et al.
Acta Dermato-Venereologica|June 1, 2017
A Review of 52 Pedigrees with Epidermolysis Bullosa Simplex Identifying Ten Novel Mutations in KRT5 and KRT14 in AustraliaEmma N Kim, Adam G Harris, Linda J Bingham, et al.
American Journal of Clinical Dermatology|July 7, 2019
Artificial Intelligence in Dermatology-Where We Are and the Way to the Future: A ReviewDaniel T Hogarty, John C Su, Kevin Phan, et al.
The British Journal of Dermatology|July 13, 2022
The association between domestic hard water and eczema in adults from the UK Biobank cohort studyDiego J Lopez, Ankur Singh, Nilakshi T Waidyatillake, et al.
JAAD International|August 19, 2021
Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional studyJohn C Su, Nikolay Murashkin, Andreas Wollenberg, et al.
Acta Dermato-Venereologica|March 29, 2017
Debunking the Myth of Wool Allergy: Reviewing the Evidence for Immune and Non-immune Cutaneous ReactionsMichaela Zallmann, Pete K Smith, Mimi L K Tang, et al.
American Journal of Clinical Dermatology|May 15, 2023
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical StudyLawrence F Eichenfield, Richard G Gower, JinHua Xu, et al.
American Journal of Clinical Dermatology|March 27, 2020
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)Joel Schlessinger, Julie S Shepard, Richard Gower, et al.
Journal of the American Academy of Dermatology|December 21, 2013
Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)Clement C H Loh, Jaehwan Kim, John C Su, et al.
Pageof 5